Xconomy: Boston News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink	Frank Vinluan	12/11/19	National
Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics	Sarah de Crescenzo	12/11/19	Boston
Flexion Co-Founder, Chief Scientific Officer Neil Bodick to Retire	Frank Vinluan	12/10/19	Boston
Replimune Taps Ex-Merrimack Exec for Chief Financial Officer Post	Frank Vinluan	12/10/19	Boston
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test	Frank Vinluan	12/10/19	Boston
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs	Frank Vinluan	12/10/19	New York
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule	Frank Vinluan	12/09/19	New York
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets	Melissa Fassbender	12/09/19	Boston
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug	Sarah de Crescenzo	12/06/19	San Diego
Akcea Therapeutics Appoints Alex Howarth Chief Operating Officer	Frank Vinluan	12/06/19	Boston
FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal	Frank Vinluan	12/06/19	National
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More	Sarah de Crescenzo	12/06/19	National
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results	Sarah de Crescenzo	12/05/19	National
FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder	Frank Vinluan	12/05/19	Boston
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%	Frank Vinluan	12/05/19	Boston
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug	Sarah de Crescenzo	12/05/19	San Diego
Avrobio’s Gabriel Cohn Joins Homology as Chief Medical Officer	Frank Vinluan	12/04/19	Boston
Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding	Melissa Fassbender	12/04/19	Boston
Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption	Bryony Winn	12/04/19	Raleigh Durham
Repare Therapeutics Taps Clementia Pharma’s Steve Forte As Its New CFO	Sarah de Crescenzo	12/03/19	Boston
Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down	Rob Coppedge	12/03/19	Seattle
Caraway Therapeutics Names Martin Williams as CEO	Melissa Fassbender	12/03/19	Boston
IFM’s Glick Becomes Executive Chairman, Seidel Promoted to CEO	Frank Vinluan	12/02/19	Boston
Agenus Chief Technology Officer Alex Duncan to Depart in January	Frank Vinluan	12/02/19	Boston
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator	Frank Vinluan	12/02/19	Boston
La Jolla Pharma’s Share Price Halves On Trial End, CEO Departure	Sarah de Crescenzo	11/26/19	San Diego
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule	Frank Vinluan	11/25/19	San Francisco
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M	Frank Vinluan	11/25/19	Boston
Axcella Taps Incyte’s Laurent Chardonnet as Chief Financial Officer	Sarah de Crescenzo	11/25/19	Boston
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B	Frank Vinluan	11/25/19	New York
Page 1 of 661	next page »